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Introduction
With a financial burden estimated in excess of $223 billion in the United States alone (Bouchery et al., 2011) , ethanol (alcohol) abuse has widespread negative consequences for public health and has been implicated in 79,000 deaths annually (Stahre et al., 2004) . Not all excessive ethanol consumption is the same, however, and different forms of aberrant alcohol use are associated with different drinking trajectories and negative consequences (Cleveland et al., 2013; Gueorguieva et al., 2012; King et al., 2011; Mota et al., 2013) . It is therefore important to explore the major subtypes of problematic alcohol use and their associated mechanisms and consequences.
One such subtype, binge drinking, is a hazardous, yet common occurrence in the United States. The National Institute on Alcohol Abuse and Alcoholism defines binge drinking (BD) as a pattern of drinking that brings blood ethanol concentration (BEC) levels to 80 mg/dl in a short period of~2 h which can typically be achieved after four drinks for women and five drinks for men. This level of ethanol consumption lies in between light or social consumption and the extreme levels typically seen in dependent individuals. BD is also defined by periodic, rather than continuous drinking and has been associated with increased risk of car accidents, sexual assault, personal injury, and ethanol poisoning. Moreover, heavy or frequent BD may lead to a loss of control over alcohol consumption, and the development of alcohol use disorders (Courtney and Polich, 2009). Whether or not BD is associated with a progression towards dependence in the clinical literature is not yet clear (Chassin et al., 2002; Courtney and Polich, 2009; Hasin and Beseler, 2009; King et al., 2011) , however the new spectrum of alcohol use disorder diagnosis presented in the DSM-5 is arguably more inclusive for BD behavior than was previously seen with the DSM-IV TR. Nevertheless, one in six adults in the United States reported engaging in BD about four times per month in 2010, consuming roughly eight drinks in each binge episode (Center for Disease Control and Prevention, 2012). Thus, there is a critical need to better understand the neurocircuitry engaged by BD, as well as how this neurocircuitry is altered by repeated bouts of BD, for informed progress in the treatment, intervention, and prevention of alcohol use disorders.
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